Jenny Maloney

Dr. Jenny Maloney

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
NBN. R. Barash
N. R. Barash
JMJenny Maloney
Jenny Maloney
SSSteven Singer
Steven Singer
SDS. C. Dawson
S. C. Dawson
Giardia lamblia is the most frequently identified protozoan cause of intestinal infection. Over 200 million people are estimated to have acute or chronic giardiasis, with infection rates approaching 90% in areas where Giardia is endemic. Despite its significance in global health, the mechanisms of pathogenesis associated with giardiasis remain unclear, as the parasite neither produces a known toxin nor induces a robust inflammatory response. Giardia colonization and proliferation in the small intestine of the host may, however, disrupt the ecological homeostasis of gastrointestinal commensal microbes and contribute to diarrheal disease associated with giardiasis. To evaluate the impact of Giardia infection on the host microbiota, we used culture-independent methods to quantify shifts in the diversity of commensal microbes throughout the gastrointestinal tract in mice infected with Giardia . We discovered that Giardia 's colonization of the small intestine causes a systemic dysbiosis of aerobic and anaerobic commensal bacteria. Specifically, Giardia colonization is typified by both expansions in aerobic Proteobacteria and decreases in anaerobic Firmicutes and Melainabacteria in the murine foregut and hindgut. Based on these shifts, we created a quantitative index of murine Giardia -induced microbial dysbiosis. This index increased at all gut regions during the duration of infection, including both the proximal small intestine and the colon. Giardiasis could be an ecological disease, and the observed dysbiosis may be mediated directly via the parasite's unique anaerobic fermentative metabolism or indirectly via parasite induction of gut inflammation. This systemic alteration of murine gut commensal diversity may be the cause or the consequence of inflammatory and metabolic changes throughout the gut. Shifts in the commensal microbiota may explain observed variations in giardiasis between hosts with respect to host pathology, degree of parasite colonization, infection initiation, and eventual clearance.

1 September 2023 in Journal of Eukaryotic Microbiology
Verified
Journal Article
Closed access
MSMonica Santin
Monica Santin
Ana M. FigueiredoAna M. Figueiredo
Ana M. Figueiredo
AMAleksey Molokin
Aleksey Molokin
NGNadja S George
Nadja S George
PKPamela C. Köster
Pamela C. Köster
JMJenny Maloney
Jenny Maloney

23 December 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
JMJenny Maloney
Jenny Maloney
AMAleksey Molokin
Aleksey Molokin
RSRaimundo Seguí
Raimundo Seguí
Pablo MaravillaPablo Maravilla
Pablo Maravilla
FMFernando Martínez-Hernández
Fernando Martínez-Hernández
MSMonica Santin
Monica Santin
Three recent studies of Blastocystis epidemiology in mammalian hosts identified four novel sequences that appeared to share B. lapemi as the most similar sequence. However, full-length ssu rRNA gene sequences were not available to confirm the validity of these new subtypes. In the present study, Nanopore MinION sequencing was used to obtain full-length reference sequences for each of the new subtypes. Additionally, phylogenetic analyses and pairwise distance comparisons were performed to confirm the validity of each of these new subtypes. We propose that the novel sequences described in this study should be assigned the subtype designations ST35-ST38. The full-length reference sequences of ST35-ST38 will assist in accurate sequence descriptions in future studies of Blastocystis epidemiology and subtype diversity.

22 June 2023 in International Journal for Parasitology
Verified
Journal Article
Open access
CSChristen Rune Stensvold
Christen Rune Stensvold
RBRebecca P.K.D. Berg
Rebecca P.K.D. Berg
JMJenny Maloney
Jenny Maloney
AMAleksey Molokin
Aleksey Molokin
MSMonica Santin
Monica Santin
Molecular characterisation of endobionts that are shared among human and non-human hosts can help shed light on the epidemiology and inform studies that aim to unravel the role of these organisms in health and disease. Two of the most common of shared endobionts include the single-celled intestinal protists Blastocystis and Entamoeba. Here, we present the first known data on genetic diversity and host specificity of these two genera in Greenland. Faecal DNA samples from 243 muskoxen and 44 sheep were submitted to metabarcoding of nuclear small subunit ribosomal DNA. Entamoeba- and Blastocystis-specific sequences were clustered, and consensus sequences were subjected to taxonomic query. Using MinION-based sequencing, near-complete nuclear small subunit ribosomal DNA sequences were obtained from four faecal samples. Of the 243 muskox samples, 180 (74%) and 19 (8%) were positive for Blastocystis and Entamoeba, respectively. Forty (91%) and six (14%) of the 44 sheep samples were positive for Blastocystis and Entamoeba, respectively. Blastocystis subtypes (ST) 10, 14, 21, 24-26, and a novel subtype (ST40) were identified. Colonisation by more than one subtype was common. ST40 was common in muskoxen but limited to Northeast Greenland. Entamoeba bovis and the E. bovis-associated ribosomal lineages (RL) 1 and 8 were found, and three conditional lineages (CL) 3, 4, and 10 were confirmed; CL10 was promoted to RL12. Several novel lineages were identified, all of which were linked to the E. bovis complex. In conclusion, Blastocystis was far more common than Entamoeba and found in approximately three of every four animals; both can be considered common colonisers of large herbivorous mammals in Greenland. Multiple subtypes/lineages of both genera were commonly observed, some of which were novel, but most of which are seen in many other parts of the world.

6 October 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
FSFakhriddin SARZHANOV
Fakhriddin SARZHANOV
FAFunda DOGRUMAN AL
Funda DOGRUMAN AL
MSMonica Santin
Monica Santin
JMJenny Maloney
Jenny Maloney
AGAyse Semra Gureser
Ayse Semra Gureser
ATAysegul Taylan-Ozkan
Aysegul Taylan-Ozkan
Introduction: The clinical significance ofBlastocystissp. andDientamoeba fragilisin patients with gastrointestinal symptoms is a controversial issue. Since the pathogenicity of these protists has not been fully elucidated, testing for these organisms is not routinely pursued by most laboratories and clinicians. Thus, the prevalence of these organisms and the subtypes ofBlastocystissp. in human patients in Turkey are not well characterized. This study aimed to determine the prevalence ofBlastocystissp. andD.fragilisin the diarrheic stool samples of immunodeficient and immunocompetent patients using conventional and molecular methods and to identifyBlastocystissp. subtypes using next generation sequencing.Material and methods: Individual stool specimens were collected from 245 immunodeficient and 193 immunocompetent diarrheic patients between March 2017 and December 2019 at the Gazi University Training and Research Hospital in Ankara, Turkey. Samples were screened forBlastocystissp. andD.fragilisby conventional and molecular methods. Molecular detection of both protists was achieved by separate qPCRs targeting a partial fragment of theSSUrRNA gene. Next generation sequencing was used to identifyBlastocystissp. subtypes.Results: The prevalence ofBlastocystissp. andD.fragiliswas 16.7% and 11.9%, respectively as measured by qPCR. The prevalence ofBlastocystissp. andD.fragiliswas lower in immunodeficient patients (12.7% and 10.6%, respectively) compared to immunocompetent patients (21.8% and 13.5%, respectively). FiveBlastocystissp. subtypes were identified and the following subtype distribution was observed: ST3 54.4% (n = 37), ST2 16.2% (n = 11), ST1 4.4% (n = 3), ST6 2.9% (n = 2), ST4 1.5% (n = 1), ST2/ST3 11.8% (n = 8) and ST1/ST3 8.8% (n = 6). There was no statistically significant difference in the distribution ofBlastocystissp. subtypes between immunocompetent and immunodeficient patients.Conclusion and recommendation: Our findings demonstrated thatBlastocystissp. andD.fragilisare commonly present in immunocompetent and immunodeficient patients with diarrhea. This study is the first to use next generation sequencing to address the presence ofBlastocystissp. mixed subtypes and intra-subtype variability in clinical samples in Turkey.

5 May 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
JMJenny Maloney
Jenny Maloney
MSMonica Santin
Monica Santin
Blastocystis is a common food- and water-borne intestinal protist parasite of humans and many other animals. Blastocystis comprises multiple subtypes (STs) based on variability within the small subunit ribosomal (SSU rRNA) RNA gene. Though full-length reference sequences of the SSU rRNA gene are a current requirement to name a novel Blastocystis subtype, full-length reference sequences are not currently available for all subtypes. In the present study, Oxford Nanopore MinION long-read sequencing was employed to generate full-length SSU rRNA sequences for seven new Blastocystis subtypes for which no full-length references currently exist: ST21, ST23, ST24, ST25, ST26, ST27, and ST28. Phylogenetic analyses and pairwise distance matrixes were used to compare full-length and partial sequences of the two regions that are most commonly used for subtyping. Analyses included Blastocystis nucleotide sequences obtained in this study (ST21 and ST23–ST28) and existing subtypes for which full-length reference sequences were available (ST1–ST17 and ST29). The relationships and sequence variance between new and existing subtypes observed in analyses of different portions of the SSU rRNA gene are discussed. The full-length SSU rRNA reference sequences generated in this study provide essential new data to study and understand the relationships between the genetic complexity of Blastocystis and its host specificity, pathogenicity, and epidemiology.